Investing in people's development
and well-being since 2005
Skogsro, consisting of three quality leading companies in northern Sweden focusing on the care and treatment of children and young people, has joined the Atviva group.
Read the full article →The board of Atleva Specialistvård AB has appointed Karl Johansson Bäckgren as the new CEO. During the autumn, there will be another positive change when the board is strengthened with former regional director Ann-Sofi Lodin and Carsten Browall, board member of Bure Equity, among others.
Read the full article →The Board of Directors of Atleva Specialistvård AB has appointed Karl Johansson Bäckgren as new CEO.
Read the full article →CTR acquires Lund-based topical pharmaceuticals company
Read the full article →CTR establishes CTC Netherlands BV in Groningen.
Read the full article →Center for Translational Research AB acquires the contract company A+ Science.
Read the full article →Atleva Specialist vård Göteborg (Fotcenter, Handcenter and Smärthjälpen) is now located in new premises in GoCo Health Innovation City in Mölndal.
Read the full article →Bengt Dahlström, founder of the Center for Translational Research, has handed over the gavel to Hans Andreasson after seven years as chairman of the group.
Read the full article →CTR acquires Admescope Sweden, which changes its name to Metasafe.
Read the full article →Atvexa AB (publ) ("Atvexa") has, as previously communicated, applied for delisting of Atvexa's B-share from Nasdaq Stockholm on the grounds that DeMina Skolintressenter AB holds more than 90 per cent of the shares and votes in Atvexa and has requested compulsory redemption of the remaining shares in Atvexa.
Read the full article →On 11 July 2022, Peter Weiderman, Lars Brune, Sara Karlin and Katarina Sjögren, through DeMina Skolintressenter AB ("DeMina"), announced a recommended public tender offer to the shareholders of Atvexa AB (publ) ("Atvexa" and the "Offer", respectively). On 11 August 2022, DeMina announced that the Offer has been accepted to the extent that DeMina holds more than 90 per cent. of the shares and votes in Atvexa and that the Offer is being completed.
Read the full article →On 11 August 2022, DeMina announced the completion of the Offer and the extension of the acceptance period until 19 August 2022. Following the extended acceptance period, the Offer has been accepted to the extent that DeMina holds approximately 99.5 per cent. of the shares and approximately 99.9 per cent. of the votes in Atvexa after completion of the Offer. DeMina is not extending the acceptance period further and the Offer is now closed.
Read the full article →DeMina is completing the Offer and at the same time extending the acceptance period until 19 August 2022 to give remaining shareholders an additional opportunity to accept the Offer.
Read the full article →This statement is made by the independent bid committee of the board of directors of Atvexa AB (publ) (the "Committee") ("the Company" or "Atvexa") in accordance with section II.19 of the Nasdaq Stockholm Takeover Rules (the "Takeover Rules").
Read the full article →Narva Åderbråckscenter AB will become a wholly owned subsidiary of Atveda AB, a long-term owner-operated company in specialist care founded by entrepreneurs and for entrepreneurs. In connection with the acquisition, Narva's current owners and managers will become co-owners of Atveda through reinvestment and new investment. This is the second acquisition Atveda has made since its inception in the fall of 2021.
Read the full article →The digital funeral home Fenix has conducted 10,000 funerals in Sweden and the UK. Now it's aiming to expand to more countries - and fill its coffers with SEK 69 million. "In Sweden, we have a business that is growing profitably," says Fenix co-founder Charlotte Runius.
Read the full article →Atvexa has signed an agreement for three new establishments in Germany with space for 200 pre-school children. The projects are being carried out in close cooperation with real estate partners, city councils and regional authorities in Hamburg and Bavaria and are scheduled to be ready in 2023-2024.
Read the full article →The newly formed company within the CTR group will help companies with the final regulatory steps in a drug's path to marketing authorisation
Read the full article →As of March 1, 2022, Suzanne Iverson Hemberg will succeed Elinor Hahne and be appointed new CEO of Toxicology Knowledge Team AB (TKT) in Sweden.
Read the full article →Atleva Specialistvård AB becomes a wholly owned subsidiary of Atveda AB, a long-term owner company in specialist care founded by entrepreneurs and for entrepreneurs. The acquisition is made through a combination of reinvestment and new issue of current owners and management persons in Atleva and Atveda.
Read the full article →Investing in human developmentand well-being since 2005
Fleminggatan 18, 112 26 Stockholm
Visiting address:
Convendum, Fleminggatan 18
E-mail: info@atnotera.se